Consensus
The community is strongly leaning bullish on Novo Nordisk at 73%, based on 4 forecasts. Forecasters are in moderate agreement.
Resolves YES if Novo Nordisk's price 12 months out is above its baseline price.
Share your read on this question — the best forecasters show their work.
See the whole nvo discussion →